SCHEMBL21797

SCHEMBL21797

O1OOO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lithium SCHEMBL31213434 0.87
SCHEMBL29727296 0.58
SCHEMBL7114151 0.58
Hydrogen Sulfide SCHEMBL15941638 0.58
SCHEMBL8022409 0.41
SCHEMBL2286219 0.33
Potassium Ion SCHEMBL23462163 0.00 CA4 (0.50)
Methane SCHEMBL23795058 0.00
Water SCHEMBL25437472 0.00
Potassium Ion SCHEMBL23462032 0.00 CA4 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 12095 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118978688-A Synthesis method and application of lithium membrane electrode material based on tetraoxetane 深圳市地博环保科技有限公司 2024-11-19 CN claimed
CN-118522949-A Electrolyte based on trioxychain ether and application thereof 安徽工业大学 2024-08-20 CN claimed
CN-118307504-A Orange ketone derivative or analogue, preparation method, pharmaceutical composition and application thereof 中国科学院上海药物研究所 2024-07-09 CN claimed
CN-118265696-A Aryl carboxylic acid compound and application thereof in preparation of Mrgpr X &lt; 4 &gt; inhibitor 深圳博瑞医药科技有限公司 2024-06-28 CN claimed
CN-118251393-A Novel substituted sulfonylurea compounds as inhibitors of interleukin-1 activity 唯久生物技术(苏州)有限公司 2024-06-25 CN claimed
EP-3551625-B1 HETEROCYCLIC INHIBITORS OF MCT4 VETTORE LLC (US) 2024-06-12 EP claimed
CN-118159541-A Gonadotropin releasing hormone antagonist and preparation method and application thereof 山东绿叶制药有限公司 2024-06-07 CN claimed
CN-118159530-A Compounds for the treatment of pain, in particular neuropathic pain and/or other diseases or disorders associated with AT2R and/or AT2R mediated signalling 康福治疗有限公司 2024-06-07 CN claimed
EP-4377307-A1 COMPOUNDS FOR THE TREATMENT OF PAIN, IN PARTICULAR NEUROPATHIC PAIN, AND/OR OTHER DISEASES OR DISORDERS THAT ARE ASSOCIATED WITH AT2R AND/OR AT2R MEDIATED SIGNALING Confo Therapeutics N.V. (BE) 2024-06-05 EP claimed
EP-4378936-A1 BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUND AND USE THEREOF AS ANDROGEN RECEPTOR DEGRADER Hinova Pharmaceuticals Inc. (CN) 2024-06-05 EP claimed
US-5310724-A Pre- and postemergence; plant growth regulators FMC CORPORATION (US) 1994-05-10 US claimed
CN-1083805-A 7-(replacement)-9-[(substituted glycyl) amido]-6-demethylation-6-deoxytetra cycline AMERICAN CYANAMID CO (US) 1994-03-16 CN claimed
EP-0582788-A1 7-(Substituted)-9- (substituted glycyl)-amido)-6-demethyl-6-deoxytetracyclines AMERICAN CYANAMID COMPANY (US) 1994-02-16 EP claimed
EP-0582789-A1 Novel 7-(substituted)-8-(substituted)-9- (substituted glycyl)amido -6-demethyl-6-deoxytetracyclines AMERICAN CYANAMID COMPANY (US) 1994-02-16 EP claimed
EP-0582810-A1 Novel 7-(substituted)-8-(substituted)-9-(substituted amino)-6-demethyl-6-deoxyetracyclines as antibiotic agents AMERICAN CYANAMID COMPANY (US) 1994-02-16 EP claimed
EP-0582829-A1 9-(substituted glycyl) amido - 6-demethyl-6-deoxytetracyclines as antibiotic agents AMERICAN CYANAMID COMPANY (US) 1994-02-16 EP claimed
CN-1077199-A THERAPEUTIC NUCLEOSIDES WELLCOME FOUND (GB) 1993-10-13 CN claimed
WO-1993013778-A1 THERAPEUTIC NUCLEOSIDES THE WELLCOME FOUNDATION LIMITED (GB) 1993-07-22 WO claimed
US-4645773-A MUSCLE RELAXANTS, ANTIEPILEPTIC AGENTS, SEDATIVES, TRANQUILIZERS SCHERING AKTIENGESELLSCHAFT (DE) 1987-02-24 US claimed
US-3953470-A Substituted prostaglandin derivatives SYNTEX (U.S.A.) INC. (US) 1976-04-27 US claimed